State of the art procedures towards reactive [(18)F]fluoride in PET tracer synthesis

por Haveman, Lizeth Y. F., Vugts, Danielle J., Windhorst, Albert D.
Publicado 2023

Feasibility of PET/CT system performance harmonisation for quantitative multicentre (89)Zr studies

por Kaalep, Andres, Huisman, Marc, Sera, Terez, Vugts, Danielle, Boellaard, Ronald
Publicado 2018

The new Regulation on clinical trials in relation to radiopharmaceuticals: when and how will it be implemented?

por Peñuelas, Iván, Vugts, Daniëlle J., Decristoforo, Clemens, Elsinga, Philip H.
Publicado 2019

State of the Art in Radiolabeling of Antibodies with Common and Uncommon Radiometals for Preclinical and Clinical Immuno-PET

por Chomet, Marion, van Dongen, Guus A. M. S., Vugts, Danielle J.
Publicado 2021

PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET

por van Dongen, Guus A. M. S., Poot, Alex J., Vugts, Danielle J.
Publicado 2012

PET Imaging of Microglial Activation—Beyond Targeting TSPO

por Janssen, Bieneke, Vugts, Danielle J., Windhorst, Albert D., Mach, Robert H.
Publicado 2018

Towards PET imaging of the dynamic phenotypes of microglia

por Beaino, Wissam, Janssen, Bieneke, Vugts, Danielle J., de Vries, Helga E., Windhorst, Albert D.
Publicado 2021

The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor

por Högnäsbacka, Antonia, Poot, Alex J., Vugts, Danielle J., van Dongen, Guus A. M. S., Windhorst, Albert D.
Publicado 2022

The Race for Hydroxamate-Based Zirconium-89 Chelators

por Feiner, Irene V. J., Brandt, Marie, Cowell, Joseph, Demuth, Tori, Vugts, Daniëlle, Gasser, Gilles, Mindt, Thomas L.
Publicado 2021

Immuno-PET Imaging of Atherosclerotic Plaques with [(89)Zr]Zr-Anti-CD40 mAb—Proof of Concept

por Poels, Kikkie, Schreurs, Maxime, Jansen, Matthijs, Vugts, Danielle J., Seijkens, Tom T. P., van Dongen, Guus A. M. S., Lutgens, Esther, Beaino, Wissam
Publicado 2022

Evaluating N‐difluoromethyltriazolium triflate as a precursor for the synthesis of high molar activity [(18)F]fluoroform

por Pees, Anna, Vosjan, Maria J. W. D., Chai, Jin Young, Cha, Hyojin, Chi, Dae Yoon, Windhorst, Albert D., Vugts, Danielle J.
Publicado 2021

The tumor targeting performance of anti-CD166 Probody drug conjugate CX-2009 and its parental derivatives as monitored by (89)Zr-immuno-PET in xenograft bearing mice

por Chomet, Marion, Schreurs, Maxime, Nguyen, Margaret, Howng, Bruce, Villanueva, Ruth, Krimm, Michael, Vasiljeva, Olga, van Dongen, Guus A.M.S, Vugts, Danielle J.
Publicado 2020

Pilot study of (89)Zr-bevacizumab positron emission tomography in patients with advanced non-small cell lung cancer

por Bahce, Idris, Huisman, Marc C, Verwer, Eline E, Ooijevaar, Rogier, Boutkourt, Firdaouss, Vugts, Danielle J, van Dongen, Guus AMS, Boellaard, Ronald, Smit, Egbert F
Publicado 2014

Performance of (89)Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma

por Jauw, Yvonne W. S., Zijlstra, Josée M., de Jong, Daphne, Vugts, Danielle J., Zweegman, Sonja, Hoekstra, Otto S., van Dongen, Guus A. M. S., Huisman, Marc C.
Publicado 2017

Novel Thienopyrimidine-Based PET Tracers for P2Y(12) Receptor Imaging in the Brain

por van der Wildt, Berend, Janssen, Bieneke, Pekošak, Aleksandra, Stéen, E. Johanna L., Schuit, Robert C., Kooijman, Esther J. M., Beaino, Wissam, Vugts, Danielle J., Windhorst, Albert D.
Publicado 2021

Correction to Novel Thienopyrimidine-Based PET Tracers for P2Y(12) Receptor Imaging in the Brain

por van der Wildt, Berend, Janssen, Bieneke, Pekošak, Aleksandra, Stéen, E. Johanna L., Schuit, Robert C., Kooijman, Esther J. M., Beaino, Wissam, Vugts, Danielle J., Windhorst, Albert D.
Publicado 2022

Synthesis and Preclinical Evaluation of [Methylpiperazine-(11)C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase

por Högnäsbacka, Antonia A., Poot, Alex J., Kooijman, Esther, Schuit, Robert C., Schreurs, Maxime, Verlaan, Mariska, Beaino, Wissam, van Dongen, Guus A. M. S., Vugts, Danielle J., Windhorst, Albert D.
Publicado 2023

Tumour targeting and radiation dose of radioimmunotherapy with (90)Y-rituximab in CD20+ B-cell lymphoma as predicted by (89)Zr-rituximab immuno-PET: impact of preloading with unlab...

por Muylle, Kristoff, Flamen, Patrick, Vugts, Danielle J., Guiot, Thomas, Ghanem, Ghanem, Meuleman, Nathalie, Bourgeois, Pierre, Vanderlinden, Bruno, van Dongen, Guus A. M. S., Everaert, Hendrik, Vaes, Mélanie, Bron, Dominique
Publicado 2015

B-cell imaging with zirconium-89 labelled rituximab PET-CT at baseline is associated with therapeutic response 24 weeks after initiation of rituximab treatment in rheumatoid arthri...

por Bruijnen, Stefan, Tsang-A-Sjoe, Michel, Raterman, Hennie, Ramwadhdoebe, Tamara, Vugts, Daniëlle, van Dongen, Guus, Huisman, Marc, Hoekstra, Otto, Tak, Paul-Peter, Voskuyl, Alexandre, van der Laken, Conny
Publicado 2016

Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [(89)Zr]Zr-DFO-PEG(5)-Tz

por Lumen, Dave, Vugts, Danielle, Chomet, Marion, Imlimthan, Surachet, Sarparanta, Mirkka, Vos, Ricardo, Schreurs, Maxime, Verlaan, Mariska, Lang, Pauline A., Hippeläinen, Eero, Beaino, Wissam, Windhorst, Albert D., Airaksinen, Anu J.
Publicado 2022